NCT00496587 2017-07-19Capecitabine, Gemcitabine, and Bevacizumab in Combination for Patients With Sarcomatoid Renal Cell CarcinomaM.D. Anderson Cancer CenterPhase 2 Completed34 enrolled 9 charts